International directory enquiries こちら fosamax tablete cena At the press conference Currie also presented data from an analysis of second-line therapy, comparing the combination of metformin and sulfonylureas, in 34,000 patients, with the combination of metformin and DPP-4 inhibitors, or glistens, in 8,000 patients. Overall there were 1,200 deaths. There were 16.0 deaths per 1,000 patient-years in the metformin-sulfonylurea group versus 7.3 for the metformin-DPP-4 group. After adjusting for baseline characteristics Currie said there was a significant 35% increase in death in the metformin-sulfonylurea group.
|